1Wang H,Li Q,Shao L,et al.Expression of matrix metalloproteinase-2,-9,-14,and tissue inhibitors of metalloproteinase-1,-2,-3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy[J].Biol Reprod,2001,65 (1):31-40.
2Shalev E,Goldman S,Ben-Shlomo I.The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulose cells:comparison between women with PCOS and normal ovulatory women[J].Mol Hum Reprod,2001,7(4):325-331.
3Jokimaa V,Oksjoki S,Kujari H,et al.Altered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages[J].Mol Hum Reprod,2002,8(12):1111-1116.
6Purcell TL, Given R, Chwalisz K, et al. Nitric oxide synthase distribution during implantation in the mouse[J]. Mol Hum Reprod, 1999,5(5) :467-475.
7Shiraishi S, Nakagawa K, Kinukawa N, et al. Immunohistochemical localization of vascular endothelial growth factor in the human placenta[J]. Placenta, 1996, 17(2-3):111-121.
8Norman JE, Thompson AJ, Teller JF, et al. Myometrial constitutive nitric oxide synthase expression is increased during human pregnancy[J]. Mol Hum Reprod, 1999,5(2) : 175-181.
9Massmann GA, Zhang J, Figueroa JP. Functional and molecular characterization of nitric oxide synthase in the endometrium and myometrium of pregnant sheep during the last third of gestation[J]. Am J Obstet Gynecol, 1999,181(1) :116-125.
10Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factors: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun, 1989,165(3) : 1198-1206.
